Division of Neuroscience, San Raffaele Rett Research Center, San Raffaele Scientific Institute Milan, Italy.
Department of Biosciences, University of Milan Milan, Italy.
Front Cell Neurosci. 2014 Aug 13;8:236. doi: 10.3389/fncel.2014.00236. eCollection 2014.
Although Rett syndrome (RTT) represents one of the most frequent forms of severe intellectual disability in females worldwide, we still have an inadequate knowledge of the many roles played by MeCP2 (whose mutations are responsible for most cases of RTT) and their relevance for RTT pathobiology. Several studies support a role of MeCP2 in the regulation of synaptic plasticity and homeostasis. At the molecular level, MeCP2 is described as a repressor capable of inhibiting gene transcription through chromatin compaction. Indeed, it interacts with several chromatin remodeling factors, such as HDAC-containing complexes and ATRX. Other studies have inferred that MeCP2 functions also as an activator; a role in regulating mRNA splicing and in modulating protein synthesis has also been proposed. Further, MeCP2 avidly binds both 5-methyl- and 5-hydroxymethyl-cytosine. Recent evidence suggests that it is the highly disorganized structure of MeCP2, together with its post-translational modifications (PTMs) that generate and regulate this functional versatility. Indeed, several reports have demonstrated that differential phosphorylation of MeCP2 is a key mechanism by which the methyl binding protein modulates its affinity for its partners, gene expression and cellular adaptations to stimuli and neuronal plasticity. As logic consequence, generation of phospho-defective Mecp2 knock-in mice has permitted associating alterations in neuronal morphology, circuit formation, and mouse behavioral phenotypes with specific phosphorylation events. MeCP2 undergoes various other PTMs, including acetylation, ubiquitination and sumoylation, whose functional roles remain largely unexplored. These results, together with the genome-wide distribution of MeCP2 and its capability to substitute histone H1, recall the complex regulation of histones and suggest the relevance of quickly gaining a deeper comprehension of MeCP2 PTMs, the respective writers and readers and the consequent functional outcomes.
尽管雷特综合征(RTT)是全球女性中最常见的严重智力残疾形式之一,但我们对 MeCP2(其突变是大多数 RTT 病例的原因)所扮演的许多角色及其与 RTT 病理生理学的相关性仍然知之甚少。有几项研究支持 MeCP2 在调节突触可塑性和动态平衡中的作用。在分子水平上,MeCP2 被描述为一种能够通过染色质紧缩抑制基因转录的抑制剂。实际上,它与几种染色质重塑因子相互作用,如含有 HDAC 的复合物和 ATRX。其他研究推断 MeCP2 的功能也可以作为激活剂;还提出了调节 mRNA 剪接和调节蛋白质合成的作用。此外,MeCP2 强烈结合 5-甲基化和 5-羟甲基胞嘧啶。最近的证据表明,正是 MeCP2 高度紊乱的结构及其翻译后修饰(PTMs)产生并调节了这种多功能性。事实上,有几项报道表明,MeCP2 的差异磷酸化是甲基结合蛋白调节其与伴侣亲和力、基因表达以及细胞对刺激和神经元可塑性的适应能力的关键机制。因此,生成磷酸缺陷型 Mecp2 敲入小鼠已经允许将神经元形态、回路形成和小鼠行为表型的改变与特定的磷酸化事件相关联。MeCP2 还经历其他几种 PTMs,包括乙酰化、泛素化和 sumoylation,其功能作用在很大程度上仍未得到探索。这些结果,以及 MeCP2 的全基因组分布及其替代组蛋白 H1 的能力,使人想起组蛋白的复杂调控,并表明需要尽快更深入地了解 MeCP2 的 PTMs、各自的书写者和读者以及随之而来的功能结果。